Company discusses the clinical progress of the ValloVax Therapeutic Vaccine at the CHIPSA Hospital
Samuel C. Wagner, President and CEO of Batu Biologics, has issued the following letter to the shareholders of the Company, providing a comprehensive update on the clinical progress of the ValloVax immune therapy:
